IJDVL Home  
 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]  
Year : 2006  |  Volume : 72  |  Issue : 5  |  Page : 346-349

Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: A randomized, double-blind, placebo controlled study

Iraji Fariba1, Asilian Ali2, Siadat Amir Hossein3, Safavai Atefeh1, Seyed Afshin Atarzadeh Behbahan1 
1 Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Pharmacology, Isfahan University of Medical Sciences, Isfahan, Iran
3 Skin diseases and Leishmaniasis Research Center, Isfahan, Iran

Correspondence Address:
Iraji Fariba
Department of Dermatology, Al-zahra Hospital, P.O. Box: 892, Isfahan
Iran

Background: Actinic keratoses (AKs) are premalignant skin lesions caused by excessive sun exposure. Aims: To explore the therapeutic efficacy of 3% diclofenac in 2.5% hyaluronan gel in the topical treatment of AK. Methods: Sixty-four lesions in 20 patients were evaluated. They were randomized to receive either the active treatment, 3% diclofenac in 2.5% hyaluronan gel or placebo, which consisted of the inactive gel vehicle, hyaluronan for a period of three months. The collected data were analyzed by using Student t- tests. Results: There was a reduction in the lesion size in 64.7% of diclofenac-treated lesions and 34.3% of control lesions during the three-month course of treatment. Only 9.3% of the lesions in the diclofenac group were completely cleared during three months of treatment. During the treatment, no significant side-effect was observed in both groups. Conclusion: Considering the malignant potential of actinic keratoses and the importance of clearing them to prevent their transformation to squamous cell carcinoma, the efficacy of diclofenac gel seen in our study seems to be low. This treatment may be useful for patients who do not tolerate other, more effective kinds of treatment for actinic keratoses.


How to cite this article:
Fariba I, Ali A, Hossein SA, Atefeh S, Atarzadeh Behbahan SA. Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: A randomized, double-blind, placebo controlled study.Indian J Dermatol Venereol Leprol 2006;72:346-349


How to cite this URL:
Fariba I, Ali A, Hossein SA, Atefeh S, Atarzadeh Behbahan SA. Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: A randomized, double-blind, placebo controlled study. Indian J Dermatol Venereol Leprol [serial online] 2006 [cited 2019 Dec 15 ];72:346-349
Available from: http://www.ijdvl.com/article.asp?issn=0378-6323;year=2006;volume=72;issue=5;spage=346;epage=349;aulast=Fariba;type=0


 

Sunday, December 15, 2019
 Site Map | Home | Contact Us | Feedback | Copyright and disclaimer